Validation of an Integrated Digital Solution (SUNrise®) Versus Polysomnography for Obstructive Sleep Apnea Diagnosis
SUNSAS
Validation d'Une Solution Digitale intégrée (SUNrise®) d'Analyse Automatique Des Mouvements Mandibulaires Par Intelligence Artificielle Versus Polysomnographie Pour le Diagnostic du Syndrome d'Apnées Obstructives du Sommeil
1 other identifier
interventional
848
1 country
19
Brief Summary
Validation of an integrated digital solution (SUNrise®) of mandibular movement automatic analysis by artificial intelligence versus polysomnography for obstructive sleep apnea diagnosis: a prospective, randomized, parallel-arm, open-label, multicenter, national, controlled study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2021
Typical duration for not_applicable
19 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 27, 2021
CompletedFirst Posted
Study publicly available on registry
September 27, 2021
CompletedStudy Start
First participant enrolled
October 28, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 7, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 7, 2024
CompletedDecember 6, 2024
December 1, 2024
2.9 years
August 27, 2021
December 5, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Change in daily sleepiness
To determine the non-inferiority of Sunrise vs PSG on sleepiness at 3 months post-diagnosis using the Epworth Sleepiness Scale (ESS) score. The ESS score (the sum of 8 item scores, 0-3) can range from 0 to 24. The higher the ESS score, the higher the average sleep propensity in daily life.
3 months post-diagnosis
Time to diagnosis
To determine the superiority of Sunrise vs PSG in terms of time between inclusion and diagnosis appointment
Up to 12 months
Time to treatment
To determine the superiority of Sunrise vs PSG in terms of time between inclusion and treatment initiation
Up to 15 months
Change in daily sleepiness
To determine the superiority of Sunrise vs PSG on sleepiness at 3 months post-inclusion using ESS
3 months post inclusion
Secondary Outcomes (8)
Change in quality of life
3 months post inclusion visit
Change in quality of life
3 months post inclusion visit
Change in work productivity
3 months post-inclusion
cost (€)/QALY
3 months post-diagnosis
Net profit for the French social security
estimated at 3 years
- +3 more secondary outcomes
Study Arms (2)
Sunrise
EXPERIMENTALHome Sleep Test, OSA diagnosis based on mandibular movements recording
PSG
ACTIVE COMPARATORPolysomnography, OSA diagnosis based on local scoring by center
Interventions
Use of the Sunrise device for three nights to register mandibular movements that will be automatically analysed using artificial intelligence.
Eligibility Criteria
You may qualify if:
- Man or woman aged between 18 to 80 years old
- Patient referred for a suspicion of OSA
- Patient having a smartphone and internet connection at home and able to use a mobile application
- Patient affiliated to the social security system
You may not qualify if:
- Patient suffering from severe chronic obstructive or restrictive pulmonary disease with or without oxygen at the discretion of the investigator
- Patient refusing to shave his beard that could prevent him to wear the device on the chin
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sunriselead
- ICUREsearchcollaborator
Study Sites (19)
CHU Angers
Angers, 49933, France
Hôpitaux Universitaires de Paris Seine Saint-Denis (HUPSSD, AP-HP),
Bobigny, 93000, France
Nouvelle clinique Bel-Air
Bordeaux, 33073, France
CHU Bordeaux - Hôpital Pellegrin
Bordeaux, 33076, France
AP-HP Hôpital Henri Mondor
Créteil, 94000, France
Chu Grenoble Alpes,
Grenoble, 38043, France
CHRU Lille - Hôpital Roger Salengro
Lille, 59037, France
Hôpital privé la Louvière
Lille, 59800, France
CHU Lyon - Hôpital de la Croix-Rousse
Lyon, 69004, France
Hôpital Européen Marseille
Marseille, 13003, France
CHU Montpellier - Hôpital Gui-de-Chauliac
Montpellier, 34295, France
CHRU de Nancy - Hôpital d'Adultes de Brabois
Nancy, 54500, France
AP-HP Pitié Salpêtrière
Paris, 75013, France
AP-HP Hôpital Bichat-Claude Bernard
Paris, 75018, France
AP-HP CUP Hôpital Hôtel Dieu
Paris, 75181, France
CHU de Reims - Hôpital Maison Blanche
Reims, 51092, France
Polyclinique Saint-Laurent
Rennes, 35700, France
Centre du Sommeil de Grenoble
Saint-Martin-d'Hères, 38400, France
CHU de Toulouse - Hôpital Larrey
Toulouse, 31059, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jean-Louis PEPIN, Pr
CHU Grenoble Alpes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 27, 2021
First Posted
September 27, 2021
Study Start
October 28, 2021
Primary Completion
October 7, 2024
Study Completion
October 7, 2024
Last Updated
December 6, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share